drugset / Trial / NCT05990374
Therapeutic Effects and Effects on Body Fat of GLP-1 Receptor Agonists in Patients With Type 2 Diabetes for 1-4 Years
RandomizedParallel-groupTriple-blindTreatment
Summary
The efficacy of long-term treatment with different GLP-1RA (Duragtide, Semaglutide, losenatide, tirzepatide, ebenatide, etc.) was evaluated through 1-4 years of follow-up, and the effects of long-term treatment on blood glucose and body fat of patients.
Timeline
- Start
- 2023-08-01
- Primary completion
- 2024-01-01
- Completion
- 2024-01-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Duragtide | Unknown | — | Subcutaneous |
| Comparator | Semaglutide | Peptide | — | Subcutaneous |
| Comparator | Tirzepatide | Peptide | — | Subcutaneous |
| Comparator | ebenatide | Peptide | — | Subcutaneous |
| Comparator | losenatide | Unknown | — | Subcutaneous |